Anita E Qualls1, Sandra Donkervoort2, Johanna C Herkert3, Alissa M D'gama1, Diana Bharucha-Goebel2,4, James Collins5, Katherine R Chao6, A Reghan Foley2, Mirthe H Schoots7, Jan D H Jongbloed3, Carsten G Bönnemann2, Pankaj B Agrawal1. 1. Division of Newborn Medicine, Division of Genetics and Genomics, and The Manton Center for Orphan Disease Research, Boston Children's Hospital and Harvard Medical School, 300 Longwood Avenue, Boston, Massachusetts, 02115, USA. 2. Neuromuscular and Neurogenetic Disorders of Childhood, National Institutes of Health, Bethesda, Maryland, USA. 3. University of Groningen, University Medical Centre Groningen, Department of Genetics, Groningen, the Netherlands. 4. Division of Neurology, Children's National Health System, Washington, DC, USA. 5. Mercy Clinic Pediatric Neurology, Springfield, Missouri, USA. 6. Center for Mendelian Genomics at the Broad Institute of MIT and Harvard, Boston, Massachusetts, USA. 7. Department of Pathology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Abstract
INTRODUCTION: Centronuclear myopathies (CNMs) are a subtype of congenital myopathies (CMs) characterized by muscle weakness, predominant type 1 fibers, and increased central nuclei. SPEG (striated preferentially expressed protein kinase) mutations have recently been identified in 7 CM patients (6 with CNMs). We report 2 additional patients with SPEG mutations expanding the phenotype and evaluate genotype-phenotype correlations associated with SPEG mutations. METHODS: Using whole exome/genome sequencing in CM families, we identified novel recessive SPEG mutations in 2 patients. RESULTS: Patient 1, with severe muscle weakness requiring respiratory support, dilated cardiomyopathy, ophthalmoplegia, and findings of nonspecific CM on muscle biopsy carried a homozygous SPEG mutation (p.Val3062del). Patient 2, with milder muscle weakness, ophthalmoplegia, and CNM carried compound heterozygous mutations (p.Leu728Argfs*82) and (p.Val2997Glyfs*52). CONCLUSIONS: The 2 patients add insight into genotype-phenotype correlations of SPEG-associated CMs. Clinicians should consider evaluating a CM patient for SPEG mutations even in the absence of CNM features. Muscle Nerve 59:357-362, 2019.
INTRODUCTION: Centronuclear myopathies (CNMs) are a subtype of congenital myopathies (CMs) characterized by muscle weakness, predominant type 1 fibers, and increased central nuclei. SPEG (striated preferentially expressed protein kinase) mutations have recently been identified in 7 CMpatients (6 with CNMs). We report 2 additional patients with SPEG mutations expanding the phenotype and evaluate genotype-phenotype correlations associated with SPEG mutations. METHODS: Using whole exome/genome sequencing in CM families, we identified novel recessive SPEG mutations in 2 patients. RESULTS:Patient 1, with severe muscle weakness requiring respiratory support, dilated cardiomyopathy, ophthalmoplegia, and findings of nonspecific CM on muscle biopsy carried a homozygous SPEG mutation (p.Val3062del). Patient 2, with milder muscle weakness, ophthalmoplegia, and CNM carried compound heterozygous mutations (p.Leu728Argfs*82) and (p.Val2997Glyfs*52). CONCLUSIONS: The 2 patients add insight into genotype-phenotype correlations of SPEG-associated CMs. Clinicians should consider evaluating a CMpatient for SPEG mutations even in the absence of CNM features. Muscle Nerve 59:357-362, 2019.
Authors: Gerhard Schumann; Roberto Bonora; Ferruccio Ceriotti; Pascale Clerc-Renaud; Carlo A Ferrero; Georges Férard; Paul F H Franck; F Javier Gella; Wieland Hoelzel; Poul Jørgen Jørgensen; Takashi Kanno; Art Kessne; Rainer Klauker; Nina Kristiansen; Jean-Marc Lessinger; Thomas P J Linsinger; Hideo Misaki; Mauro Panteghini; Jean Pauwels; Heinz G Schimmel; Arlette Vialle; Gerhard Weidemann; Lothar Siekmann Journal: Clin Chem Lab Med Date: 2002-06 Impact factor: 3.694
Authors: C M Hsieh; S Fukumoto; M D Layne; K Maemura; H Charles; A Patel; M A Perrella; M E Lee Journal: J Biol Chem Date: 2000-11-24 Impact factor: 5.157
Authors: J A Bevilacqua; N Monnier; M Bitoun; B Eymard; A Ferreiro; S Monges; F Lubieniecki; A L Taratuto; A Laquerrière; K G Claeys; I Marty; M Fardeau; P Guicheney; J Lunardi; N B Romero Journal: Neuropathol Appl Neurobiol Date: 2011-04 Impact factor: 8.090
Authors: Pankaj B Agrawal; Christopher R Pierson; Mugdha Joshi; Xiaoli Liu; Gianina Ravenscroft; Behzad Moghadaszadeh; Tiffany Talabere; Marissa Viola; Lindsay C Swanson; Göknur Haliloğlu; Beril Talim; Kyle S Yau; Richard J N Allcock; Nigel G Laing; Mark A Perrella; Alan H Beggs Journal: Am J Hum Genet Date: 2014-07-31 Impact factor: 11.025
Authors: Ozge Ceyhan-Birsoy; Pankaj B Agrawal; Carlos Hidalgo; Klaus Schmitz-Abe; Elizabeth T DeChene; Lindsay C Swanson; Rachel Soemedi; Nasim Vasli; Susan T Iannaccone; Perry B Shieh; Natasha Shur; Jane M Dennison; Michael W Lawlor; Jocelyn Laporte; Kyriacos Markianos; William G Fairbrother; Henk Granzier; Alan H Beggs Journal: Neurology Date: 2013-08-23 Impact factor: 9.910
Authors: Hannah Campbell; Yuriana Aguilar-Sanchez; Ann P Quick; Dobromir Dobrev; Xander H T Wehrens Journal: Cardiovasc Res Date: 2021-08-29 Impact factor: 10.787
Authors: Karla G Espinosa; Salma Geissah; Linda Groom; Jonathan Volpatti; Ian C Scott; Robert T Dirksen; Mo Zhao; James J Dowling Journal: Dis Model Mech Date: 2022-05-09 Impact factor: 5.732